...
...

glenmark news

Spray lowers Covid viral load by 94%, says study

The study was conducted by Glenmark in 306 vaccinated and non-vaccinated adults suffering from symptomatic mild Covid-19, across 20 clinical sites in India. (ANI)
india news
Updated on Jul 14, 2022 03:38 am IST

Glenmark Life Sciences IPO share allotment today, listing expected on Aug 6

Glenmark Life Sciences is a leading developer and manufacturer of select high-value, non-commoditised active pharmaceutical ingredients in chronic therapeutic areas.
business
Published on Aug 03, 2021 10:56 am IST

Glenmark Life Sciences IPO to open tomorrow. Check details

Glenmark Life Sciences IPO will open for three days.
business
Published on Jul 26, 2021 10:49 am IST

Combination of antiviral drugs shows ‘no superior outcome’ for Covid treatment: Firm

The FAITH study enrolled a total of 158 hospitalised patients with moderate symptoms of Covid-19 in India.
india news
Published on Oct 10, 2020 10:04 am IST

Glenmark’s antiviral combination for moderate Covid-19 shows no clinical benefit

Mumbai-based Glenmark in July said its version of favipiravir alone showed promise in a late-stage study of patients with mild to moderate coronavirus infection.
world news
Updated on Oct 09, 2020 08:44 pm IST

Glenmark Pharma drops price of Covid-19 drug Favipiravir to Rs 75/tablet

The antiviral oral drug is marketed under the brand name FabiFlu and was formally launched in the country on June 21.
india news
Updated on Jul 13, 2020 09:28 pm IST

Glenmark’s FabiFlu gets DCGI nod as Covid-19 drug, in stores next week: All you need to know

The medicine can be administered to coronavirus patients between the age group of 18 and 75.
india news
Updated on Jun 20, 2020 10:44 pm IST

Glenmark gets India approval for favipiravir as Covid-19 treatment

Shares of Glenmark Pharmaceuticals closed at Rs 409.10 per scrip on the BSE, up 0.93 per cent from its previous close.
business
Published on Jun 19, 2020 08:25 pm IST

Glenmark to study efficacy of two antiviral drugs for treating Covid-19

Finished tablets sit inside an unsealed container during the manufacture of the Favipiravir antiviral medicine at a plant in Khimki, Russia.
india news
Updated on May 26, 2020 05:36 pm IST

Glenmark to start new phase 3 clinical trial of Covid-19 drug combination

Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so in Mumbai on Tuesday.
india news
Updated on May 26, 2020 11:50 am IST

Glenmark begins phase 3 clinical trials of favipiravir

Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so, in Mumbai on Tuesday.
india news
Updated on May 13, 2020 04:58 am IST

Glenmark gets DGCI nod for clinical trial

The DCGI approved to conduct trials on Favipiravir antiviral tablets on Covid-19 patients, making Glenmark the first pharmaceutical firm in India to be given an approval to start the trial.
business
Published on May 01, 2020 03:49 am IST

Pharma company suspends clinical trial at Jaipur hospital

The hospital had allegedly conducted the trial on 17 people from Churu district.
jaipur news
Updated on Apr 24, 2018 10:34 pm IST
View more
Home / Topic / Glenmark / News
Sign in
Sign out
Subscribe Now
Copyright © HT Digital Streams Ltd. All rights reserved.